Manufacturers Life Insurance Company, The Eye Point Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $102 Billion
- Q2 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 68,043 shares of EYPT stock, worth $542,983. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,043
Previous 76,539
11.1%
Holding current value
$542,983
Previous $1.58 Million
62.64%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EYPT
# of Institutions
163Shares Held
58.2MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$66.4 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$41.3 Million1.88% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$30 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$29.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$28.7 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $272M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...